Allergological and Toxicological Aspects in a Multiple Chemical Sensitivity Cohort

Table 5

Adverse health effects occurring in 33.3 percent of patients (11 of 33) who underwent mercury dental amalgam removal without adopting safety measures.

Patient no.	Sex	Age at diagnosis	No. of total mercury amalgam fillings	Reported adverse events	Allergy to metals∗	Blood mercury levels 𝜇g/L	Urine mercury levels 𝜇g/L	Scalp hair mercury levels 𝜇g/g	Saliva mercury levels 𝜇g/L
1	F	52	PR‡	Fever of unknown origin	Thimerosal	0.5	0.5	0.06	NA∗∗
2	F	31	2	Asthma attacks	Nickel	2.7	0.7	NA	0.7
3	F	27	2	Asthma attacks	Thimerosal nickel	59.4	4	8.2	1.3
4	M	36	PR	Tunnel vision, trigeminal neuralgia, metallic taste	Inorganic mercury	NA	NA	0.2	0.2
5	F	39	PR	Hyperosmia, asthma attacks	NA	NA	NA	NA	NA
6	F	29	5	Fever of unknown origin	NA	1.1	0.3	NA	2.4
7	F	61	2	Atypical facial pain	NA	NA	NA	2.8	2
8	F	31	PR	Fatigue, muscle pain	Nickel	NA	NA	NA	NA
9	F	58	1	Facial paresthesia, metallic taste, ocular inflammation	NA	7.6	0.5	4.03	0.7
10	F	47	2	Vertigo, asthma attacks, pricking pain in arms	NA	2.7	0.5	1.3	NA
11	M	36	2	Fatigue, muscle pain/weakness	Inorganic mercury	3.5	0.5	NA	9.2

∗Allergy to mercury: patients were tested with skin patch testing and/or lymphocyte transformation test (LTT).
‡PR: previously removed, number of mercury amalgam undefined.
∗∗NA: not analyzed.